Veru PE Ratio 2010-2024 | VERU
Current and historical p/e ratio for Veru (VERU) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Veru PE ratio as of February 20, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Veru PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-02-20 | 0.59 | 0.00 | |
| 2024-12-31 | 0.65 | $-0.20 | 0.00 |
| 2024-09-30 | 0.77 | $-0.28 | 0.00 |
| 2024-06-30 | 0.84 | $-0.48 | 0.00 |
| 2024-03-31 | 0.70 | $-0.34 | 0.00 |
| 2023-12-31 | 0.72 | $-0.75 | 0.00 |
| 2023-09-30 | 0.72 | $-1.13 | 0.00 |
| 2023-06-30 | 1.19 | $-1.38 | 0.00 |
| 2023-03-31 | 1.16 | $-1.73 | 0.00 |
| 2022-12-31 | 5.28 | $-1.43 | 0.00 |
| 2022-09-30 | 11.52 | $-1.05 | 0.00 |
| 2022-06-30 | 11.30 | $-0.59 | 0.00 |
| 2022-03-31 | 4.83 | $-0.34 | 0.00 |
| 2021-12-31 | 5.89 | $-0.20 | 0.00 |
| 2021-09-30 | 8.53 | $0.11 | 77.55 |
| 2021-06-30 | 8.07 | $-0.01 | 0.00 |
| 2021-03-31 | 10.78 | $-0.03 | 0.00 |
| 2020-12-31 | 8.65 | 0 | 0.00 |
| 2020-09-30 | 2.62 | $-0.28 | 0.00 |
| 2020-06-30 | 3.34 | $-0.16 | 0.00 |
| 2020-03-31 | 3.27 | $-0.15 | 0.00 |
| 2019-12-31 | 3.35 | $-0.20 | 0.00 |
| 2019-09-30 | 2.16 | $-0.18 | 0.00 |
| 2019-06-30 | 2.13 | $-0.27 | 0.00 |
| 2019-03-31 | 1.46 | $-0.38 | 0.00 |
| 2018-12-31 | 1.40 | $-0.39 | 0.00 |
| 2018-09-30 | 1.42 | $-0.44 | 0.00 |
| 2018-06-30 | 2.02 | $-0.40 | 0.00 |
| 2018-03-31 | 1.81 | $-0.28 | 0.00 |
| 2017-12-31 | 1.14 | $-0.27 | 0.00 |
| 2017-09-30 | 2.65 | $-0.23 | 0.00 |
| 2017-06-30 | 1.05 | $-0.19 | 0.00 |
| 2017-03-31 | 1.01 | $-0.14 | 0.00 |
| 2016-12-31 | 0.91 | $-0.08 | 0.00 |
| 2016-09-30 | 1.22 | $0.01 | 122.00 |
| 2016-06-30 | 1.26 | $0.09 | 14.00 |
| 2016-03-31 | 1.87 | $0.11 | 17.00 |
| 2015-12-31 | 1.45 | $0.17 | 8.53 |
| 2015-09-30 | 1.58 | $0.15 | 10.53 |
| 2015-06-30 | 1.80 | $0.11 | 16.36 |
| 2015-03-31 | 2.83 | $0.11 | 25.73 |
| 2014-12-31 | 3.92 | $0.06 | 65.33 |
| 2014-09-30 | 3.49 | $0.08 | 43.63 |
| 2014-06-30 | 5.51 | $0.33 | 16.70 |
| 2014-03-31 | 7.69 | $0.32 | 24.03 |
| 2013-12-31 | 8.35 | $0.43 | 19.41 |
| 2013-09-30 | 9.62 | $0.50 | 19.23 |
| 2013-06-30 | 9.54 | $0.56 | 17.04 |
| 2013-03-31 | 6.94 | $0.62 | 11.20 |
| 2012-12-31 | 6.83 | $0.57 | 11.99 |
| 2012-09-30 | 6.75 | $0.54 | 12.50 |
| 2012-06-30 | 5.48 | $0.41 | 13.37 |
| 2012-03-31 | 5.01 | $0.33 | 15.19 |
| 2011-12-31 | 4.13 | $0.26 | 15.89 |
| 2011-09-30 | 3.70 | $0.18 | 20.54 |
| 2011-06-30 | 4.48 | $0.21 | 21.34 |
| 2011-03-31 | 4.43 | $0.20 | 22.13 |
| 2010-12-31 | 5.00 | $0.26 | 19.23 |
| 2010-09-30 | 4.49 | $0.22 | 20.39 |
| 2010-06-30 | 4.48 | $0.11 | 40.69 |
| 2010-03-31 | 6.14 | $0.13 | 47.21 |
| 2009-12-31 | 4.01 | $0.14 | 28.66 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.086B | $0.017B |
| Veru Inc. engages in the development, manufacture and marketing of consumer health care products. It focuses on producing FC2 female condom which provides dual protection against unintended pregnancy and sexually transmitted infections. Veru Inc., formerly known as The Female Health Company, is headquartered in Miami, FL. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $230.977B | 28.52 |
| Boston Scientific (BSX) | United States | $155.488B | 41.98 |
| Stryker (SYK) | United States | $147.446B | 31.70 |
| EssilorLuxottica (ESLOY) | France | $140.780B | 0.00 |
| Medtronic (MDT) | Ireland | $112.764B | 16.47 |
| Lonza Group Ag (LZAGY) | Switzerland | $47.084B | 0.00 |
| Haleon (HLN) | United Kingdom | $44.818B | 29.12 |
| GE HealthCare Technologies (GEHC) | United States | $42.113B | 20.51 |
| Agilent Technologies (A) | United States | $39.025B | 25.86 |
| ResMed (RMD) | United States | $34.189B | 26.33 |
| Terumo (TRUMY) | Japan | $26.310B | 37.41 |
| Koninklijke Philips (PHG) | Netherlands | $23.527B | 16.80 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.630B | 12.95 |
| Insulet (PODD) | United States | $20.222B | 86.57 |
| Baxter (BAX) | United States | $17.074B | 12.34 |
| Sunny Optical Technology (SNPTF) | China | $11.331B | 0.00 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.245B | 0.00 |
| BellRing Brands (BRBR) | United States | $9.513B | 35.65 |
| Bio-Rad Laboratories (BIO) | United States | $8.001B | 27.70 |
| Demant (WILYY) | Denmark | $7.946B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $5.621B | 13.06 |
| Prestige Consumer Healthcare (PBH) | United States | $4.200B | 20.05 |
| ICU Medical (ICUI) | United States | $3.995B | 38.03 |
| Envista Holdings (NVST) | United States | $3.693B | 29.38 |
| Perrigo (PRGO) | Ireland | $3.443B | 10.14 |
| Haemonetics (HAE) | United States | $3.188B | 15.00 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $2.989B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.921B | 19.69 |
| QuidelOrtho (QDEL) | United States | $2.760B | 23.18 |
| LeMaitre Vascular (LMAT) | United States | $2.269B | 55.15 |
| Neogen (NEOG) | United States | $2.178B | 25.10 |
| AtriCure (ATRC) | United States | $1.914B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.484B | 25.90 |
| InMode (INMD) | Israel | $1.320B | 11.03 |
| BioLife Solutions (BLFS) | United States | $1.276B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.180B | 8.43 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.997B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.938B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.930B | 14.27 |
| Evolus (EOLS) | United States | $0.926B | 0.00 |
| CeriBell (CBLL) | United States | $0.828B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.689B | 0.00 |
| Valneva SE (VALN) | France | $0.643B | 0.00 |
| Omeros (OMER) | United States | $0.557B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.529B | 22.95 |
| Owens & Minor (OMI) | United States | $0.494B | 3.86 |
| Surmodics (SRDX) | United States | $0.492B | 0.00 |
| SNDL (SNDL) | Canada | $0.462B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.459B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.373B | 0.00 |
| ZimVie (ZIMV) | United States | $0.368B | 30.98 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.349B | 0.00 |
| Cerus (CERS) | United States | $0.323B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.321B | 58.60 |
| Viemed Healthcare (VMD) | United States | $0.310B | 29.52 |
| Sanara MedTech (SMTI) | United States | $0.309B | 0.00 |
| Quanterix (QTRX) | United States | $0.292B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.289B | 19.40 |
| Biote (BTMD) | United States | $0.260B | 5.69 |
| Canopy Growth (CGC) | Canada | $0.250B | 0.00 |
| Zynex (ZYXI) | United States | $0.236B | 49.40 |
| Sanuwave Health (SNWV) | United States | $0.231B | 3.24 |
| Brainsway (BWAY) | Israel | $0.212B | 112.80 |
| High Tide (HITI) | Canada | $0.209B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.206B | 15.39 |
| MacroGenics (MGNX) | United States | $0.181B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.174B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.163B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.160B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.140B | 17.51 |
| Jin Medical (ZJYL) | China | $0.124B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.112B | 0.00 |
| Fonar (FONR) | United States | $0.091B | 12.79 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.089B | 0.00 |
| InterCure (INCR) | Israel | $0.075B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.067B | 0.00 |
| Exagen (XGN) | United States | $0.067B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.063B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.058B | 30.00 |
| Apyx Medical (APYX) | United States | $0.055B | 0.00 |
| Hongchang (HCIL) | China | $0.051B | 0.00 |
| MariMed (MRMD) | United States | $0.050B | 0.00 |
| United-Guardian (UG) | United States | $0.050B | 14.22 |
| ImmuCell (ICCC) | United States | $0.045B | 0.00 |
| Modular Medical (MODD) | United States | $0.044B | 0.00 |
| INLIF (INLF) | $0.040B | 0.00 | |
| Safety Shot (SHOT) | United States | $0.031B | 0.00 |
| Nephros (NEPH) | United States | $0.016B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.015B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.012B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.009B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Agape ATP (ATPC) | $0.004B | 0.00 | |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Sharps Technology (STSS) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |